01 3Olanzapine pamoate
02 1cabotegravir and rilpivirine
03 5pasireotide
04 1triamcinolone acetonide
05 1triptorelin
06 3triptorelin pamoate
01 1Synergy Health AST, Inc
02 12Synergy Health AST, LLC
03 1Synergy Health, LLC
01 14U.S.A
NDC Package Code : 71161-143
Start Marketing Date : 2009-12-11
End Marketing Date : 2026-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE (300mg/2mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 71161-142
Start Marketing Date : 2009-12-11
End Marketing Date : 2026-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE (210mg/1.4mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 71161-144
Start Marketing Date : 2009-12-11
End Marketing Date : 2026-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE (405mg/2.7mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 71161-129
Start Marketing Date : 2014-12-15
End Marketing Date : 2026-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION (10mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 71161-130
Start Marketing Date : 2018-06-29
End Marketing Date : 2026-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION (15mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 71161-128
Start Marketing Date : 2014-12-15
End Marketing Date : 2026-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION (20mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 71161-127
Start Marketing Date : 2018-07-12
End Marketing Date : 2026-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION (5mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 71161-126
Start Marketing Date : 2014-12-15
End Marketing Date : 2026-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION (30mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 71161-154
Start Marketing Date : 2025-03-13
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (300mg/300mg)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 71161-135
Start Marketing Date : 2017-10-06
End Marketing Date : 2026-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE (32mg/1)
Marketing Category : DRUG FOR FURTHER PROCESSING
Steris Life Sciences is a supplier offers 5 products (APIs, Excipients or Intermediates).
Find Olanzapine Pamoate bulk offered by Steris Life Sciences
Find Pasireotide bulk offered by Steris Life Sciences
Find Rilpivirine bulk offered by Steris Life Sciences
Find Triamcinolone Acetonide bulk offered by Steris Life Sciences
Find Triptorelin Pamoate bulk offered by Steris Life Sciences
